Skip to main content
logo
Unity Biotechnology, Inc. (UNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0561
+0.0002 (0.36%)
Inactive · Last trade price on Oct 1, 2025

Unity Biotechnology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
---0.244.78-
Revenue Growth
----95.07%--
Gross Profit
-12.06-13.01-19.7-35.22-33.61-67.31
Operating Income
-27.76-28.47-38.47-55.67-56.67-91.33
Net Income
-27.5-25.99-39.86-44.47-60.73-93.84
Earnings Per Share
-1.63-1.54-2.70-4.68-10.88-18.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
16.9323.2343.294.890.07115.57
Total Debt
22.6123.5426.9950.4656.963.5
Net Cash (Debt)
-5.67-0.3116.2144.3433.1752.07
Net Cash Growth
---63.44%33.67%-36.30%-60.10%
Net Cash Per Share
-0.34-0.021.104.675.9410.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-22.04-20.87-37.09-52.41-45.06-78.33
Capital Expenditures
---0.01-0.1-0.2-0.65
Free Cash Flow
-22.04-20.87-37.1-52.51-45.26-78.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------
Operating Margin
----23589.83%-1184.47%-
Pretax Margin
----18842.80%-1269.34%-
Profit Margin
----18842.80%-1269.34%-
FCF Margin
----22250.00%-945.97%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
---164.7817.62-